Work

First case of pregnancy and childbirth in a patient implanted with an extravascular implantable cardioverter-defibrillator

Year: 2025

Type: article

Abstract: The extravascular implantable cardioverter-defibrillator (EV-ICD) was developed as an extravascular alternative to the transvenous ICD (TV-ICD).1 In contrast to the already commercially available subcutaneous ICD (S-ICD), the lead of the EV-ICD is implanted in the substernal space, enabling it to deliver anti-tachycardia and pause-prevention pacing.2 Due to the close proximity to the heart, the EV-ICD has a proven lower defibrillation threshold than the S-ICD and the generator size is therefore comparable to a transvenous device, with an output of 40J.

Source: HeartRhythm Case Reports

DOI: 10.1016/j.hrcr.2025.10.044

Authors: Kirsten M. Kooiman, Jolien A. de Veld, Willeke van der Stuijt, Reinoud E. Knops

Institutions: Amsterdam UMC Location University of Amsterdam, Amsterdam Cardiovascular Sciences

Language: English

Topic: Cardiac pacing and defibrillation studies

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,100